Venous thromboembolic disease: Clinical Practice Guidelines in Oncology

Michael B. Streiff, Paula L. Bockenstedt, Spero R. Cataland, Carolyn Chesney, Charles Eby, John Fanikos, Annemarie E. Fogerty, Shuwei Gao, Samuel Z. Goldhaber, Hani Hassoun, Paul Hendrie, Bjorn Holmstrom, Nicole Kuderer, Jason T. Lee, Michael M. Millenson, Anne T. Neff, Thomas L. Ortel, Tanya Siddiqi, Judy L. Smith, Gary C. YeeAnaadriana Zakarija, Nicole McMillian, Maoko Naganuma

Research output: Contribution to journalArticle

74 Scopus citations

Abstract

Venous thromboembolism (VTE) remains a common and life-threatening complication among patients with cancer. Thromboprophylaxis can be used to prevent the occurrence of VTE in patients with cancer who are considered at high risk for developing this complication. Therefore, it is critical to recognize the various risk factors for VTE in patients with cancer. Risk assessment tools are available to help identify patients for whom discussions regarding the potential benefits and risks of thromboprophylaxis would be appropriate. The NCCN Clinical Practice Guidelines in Oncology for VTE provide recommendations on risk evaluation, diagnosis, prevention, and treatment of VTE in patients with cancer.

Original languageEnglish (US)
Pages (from-to)1402-1429
Number of pages28
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number11
DOIs
StatePublished - Nov 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Oncology

Cite this

Streiff, M. B., Bockenstedt, P. L., Cataland, S. R., Chesney, C., Eby, C., Fanikos, J., Fogerty, A. E., Gao, S., Goldhaber, S. Z., Hassoun, H., Hendrie, P., Holmstrom, B., Kuderer, N., Lee, J. T., Millenson, M. M., Neff, A. T., Ortel, T. L., Siddiqi, T., Smith, J. L., ... Naganuma, M. (2013). Venous thromboembolic disease: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network, 11(11), 1402-1429. https://doi.org/10.6004/jnccn.2013.0163